Latest news with #JEN
Time of India
5 days ago
- Time of India
JDA engr sentenced to 4-yr imprisonment in graft case
Jodhpur: A court here Saturday sentenced a junior engineer (JEN) of Jodhpur Development Authority (JDA) to four years of rigorous imprisonment in a corruption case. The convict, identified as Kanaram, a resident of Jodhpur, had taken a bribe for granting construction permission in 2016. According to Anti-Corruption Bureau (ACB) public prosecutor Dinesh Tiwari, a complaint had been filed at the agency against Kanaram in Sept 2016 by one Dharmveer Soni stating that Kanaram demanded Rs 5,000 for preparing an inspection report required for the permission of construction. In a trap action executed by the ACB following verification of the complaint, the ACB had caught the engineer red-handed while accepting a bribe of Rs 2,000 from the complainant on Sept 21, 2016. After his arrest, the ACB had filed a chargesheet against the accused. During the hearing in the court, which lasted about nine years, statements of 17 witnesses were recorded and 37 documents were submitted in the court. Based on these evidence and arguments, Special Judge (ACB) Madhusudan Mishra, pronounced Kanaram guilty and sentenced him to three years of imprisonment and a fine of Rs 20,000 under Section 7 of the Prevention of Corruption Act. In addition to this, the court also sentenced him to four years of imprisonment along with another fine of Rs 20,000 under Sections 13(1)(D) and 13(2) of the same Act. If the fine is not paid, he will have to undergo an additional imprisonment of six months for each default.
Yahoo
28-04-2025
- Business
- Yahoo
When Should You Buy Jenoptik AG (ETR:JEN)?
Jenoptik AG (ETR:JEN), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the XTRA. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, what if the stock is still a bargain? Today we will analyse the most recent data on Jenoptik's outlook and valuation to see if the opportunity still exists. Our free stock report includes 1 warning sign investors should be aware of before investing in Jenoptik. Read for free now. Great news for investors – Jenoptik is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is €24.93, but it is currently trading at €17.66 on the share market, meaning that there is still an opportunity to buy now. However, given that Jenoptik's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. See our latest analysis for Jenoptik Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Jenoptik's earnings over the next few years are expected to increase by 38%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since JEN is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on JEN for a while, now might be the time to make a leap. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy JEN. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy. If you want to dive deeper into Jenoptik, you'd also look into what risks it is currently facing. While conducting our analysis, we found that Jenoptik has 1 warning sign and it would be unwise to ignore this. If you are no longer interested in Jenoptik, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
